| Date | Description |
|---|
| 2024-04-01 |
insert evp Manish Singh |
| 2024-04-01 |
insert person Elmar R. Alizadeh |
| 2024-04-01 |
insert person Manish Singh |
| 2024-04-01 |
update person_title David Moules: Head of Sales and Business Development => Senior Advisor, U.S. Market Access |
| 2023-10-09 |
delete general_emails in..@entityrisk.com |
| 2023-10-09 |
delete address 300 Carnegie Center, Suite 150
Princeton, New Jersey 08540 |
| 2023-10-09 |
delete email in..@entityrisk.com |
| 2023-10-09 |
delete index_pages_linkeddomain integrichain.com |
| 2023-10-09 |
delete index_pages_linkeddomain ispor.org |
| 2023-10-09 |
delete index_pages_linkeddomain yahoo.com |
| 2023-10-09 |
delete source_ip 66.29.132.106 |
| 2023-10-09 |
insert source_ip 194.195.84.84 |
| 2023-10-09 |
update primary_contact 300 Carnegie Center, Suite 150
Princeton, New Jersey 08540 => null |
| 2023-06-21 |
insert index_pages_linkeddomain yahoo.com |
| 2023-06-21 |
insert person Katie Everson |
| 2023-05-01 |
insert chairman Jeff Kindler |
| 2023-05-01 |
insert index_pages_linkeddomain ispor.org |
| 2023-05-01 |
update person_title Jeff Kindler: Chief Executive Officer of Centrexion Therapeutics; Senior Advisor to Blackstone; Advisor; McDonald 's Corporation As Executive Vice President and General Counsel => Chief Executive Officer of Centrexion Therapeutics; Senior Advisor to Blackstone; Executive Chairman; McDonald 's Corporation As Executive Vice President and General Counsel |
| 2022-12-05 |
insert person Seth Seabury |